Shin Dong-yeop
Seoul National University Hospital|Hematology and Oncology
Seoul Jongno-gu
Last updated
The clinical practice of Professor Shin Dong-yeop, specializing in the treatment of leukemia including anemia and thrombocytopenia, is supported by research achievements.
Medical opinions · Patient reviews0
No reviews yet.
If you've been treated by Shin Dong-yeop, be the first to leave a review.
Planning to see Shin Dong-yeop?
Save this doctor and find them again anytime on My page.
Ask other patients
If reviews don't answer your questions, ask patients and caregivers who have been there.
Patient stories: Hematology and Oncology
MoreHospital information
- Hospitals
- Seoul National University Hospital
- Specialties
- More Hematology and Oncology doctors
- Address
- 101 Daehak-ro, Jongno-gu, Seoul
- University
- 서울대학교 의과대학
- Appointments
- 1588-5700Book by phone (1588-5700)
Education and career
Education
- 2012–2015 Seoul National University Graduate School of Medicine, Doctor of Medicine (Molecular Oncology)
- 2010–2012 Seoul National University Graduate School of Medicine, Master of Medicine (Molecular Oncology)
- 2002–2006 Seoul National University College of Medicine, Medicine
- 1994–2001 Kyung Hee University College of Korean Medicine, Korean Medicine
Career
- 2020.3–Present Clinical Associate Professor, Division of Hematology and Oncology, Seoul National University Hospital
- 2019.3–2020.7 Visiting Scholar, Hal E. Broxmeyer Laboratory, Indiana University School of Medicine
- 2016.3–2020.2 Clinical Assistant Professor, Division of Hematology and Oncology, Seoul National University Hospital
- 2012.3–2016.2 Chief, Division of Hematology and Oncology, Korea Cancer Center Hospital
- Title: Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia.
- Journal: Korean J Intern Med
- Publication date: 2020.8
- Title: Physioxia enhances T-cell development ex vivo from human hematopoietic stem and progenitor cells.
- Journal: Stem Cells
- Publication date: 2020.8
- Title: Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults.
- Journal: PLoS One
- Publication date: 2020.8
- Title: Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study.
- Journal: Int J Hematol
- Publication date: 2020.7
- Title: Allogeneic Stem Cell Transplantation in Relapsed/Refractory multiple myeloma treatment: Is it still relevant?
- Journal: J Clin Med
- Publication date: 2020.7
Academic societies
- 2020.7–Present Acute Myeloid Leukemia/Myelodysplastic Syndrome Research Group
- 2019–2020 American Society of Hematology
- 2018.1–Present Multiple Myeloma Research Group
- 2016–2019 Korean Association for Clinical Oncology
- 2016–2017 Korean Society on Thrombosis and Hemostasis
- 2013–2015 American Association for Cancer Research
- 2012–Present Korean Society of Hematology
- 2012–Present Korean Society for Blood and Marrow Transplantation
- 2012–2014 European Society of Medical Oncology
- 2011–Present Korean Cancer Association
FAQ
- What conditions does Shin Dong-yeop treat?
- Shin Dong-yeop (Hematology and Oncology, Seoul National University Hospital) treats conditions such as Anemia/Platelet disorders, Leukemia.
- Where does Shin Dong-yeop see patients?
- In Hematology and Oncology at Seoul National University Hospital. The hospital address is 101 Daehak-ro, Jongno-gu, Seoul.
- What is Shin Dong-yeop's specialty?
- Specialty: Hematology and Oncology.
Is any information wrong?
Let us know about changes to hospital, specialty, career and so on, and we'll update it after checking.